Table 4 Top 20 enriched KEGG pathways with 79 key targets of SH003 in NSCLC
ID | Pathway Name | Term PValue Corrected with Benjamini-Hochberg | Gene Count |
|---|---|---|---|
KEGG:05200 | Pathways in cancer | 5.04E-62 | 53 |
KEGG:05417 | Lipid and atherosclerosis | 3.60E-44 | 34 |
KEGG:04933 | PI3K-Akt signaling pathway | 1.95E-35 | 33 |
KEGG:05167 | Human cytomegalovirus infection | 2.62E-38 | 31 |
KEGG:05163 | Kaposi sarcoma-associated herpesvirus infection | 1.46E-38 | 30 |
KEGG:05215 | Hepatitis B | 2.65E-37 | 28 |
KEGG:05161 | Human papillomavirus infection | 1.01E-28 | 28 |
KEGG:04151 | Proteoglycans in cancer | 9.96E-33 | 27 |
KEGG:05212 | AGE-RAGE signaling pathway in diabetic complications | 2.55E-39 | 26 |
KEGG:05205 | Prostate cancer | 9.13E-38 | 25 |
KEGG:04218 | MAPK signaling pathway | 1.12E-25 | 25 |
KEGG:05160 | Cellular senescence | 1.08E-30 | 24 |
KEGG:05162 | Hepatitis C | 1.22E-30 | 24 |
KEGG:04068 | Human immunodeficiency virus 1 infection | 1.70E-27 | 24 |
KEGG:05165 | Human T-cell leukemia virus 1 infection | 3.42E-27 | 24 |
KEGG:05418 | Measles | 3.77E-30 | 23 |
KEGG:05224 | MicroRNAs in cancer | 2.72E-22 | 23 |
KEGG:05219 | Pancreatic cancer | 1.74E-34 | 22 |
KEGG:05170 | FoxO signaling pathway | 5.74E-29 | 22 |
KEGG:04926 | Fluid shear stress and atherosclerosis | 2.17E-28 | 22 |